Former Astellas Pharma VP Joins MMS As Advisor Of Biostatistics, Submissions Planning
CANTON – MMS Holdings – a data-focused CRO – announced this week the addition of Kevin Chartier, Ph.D., as Principal Advisor of Biostatistics and Submissions Planning. Chartier will work with the biostatistics team across MMS global operations to support Sponsors with complex studies and submissions. Bringing more than 25 years of statistics experience, Chartier has held positions at Astellas Pharma, Novartis, Wyeth, Pfizer, and United BioSource Corporation across





